Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

YM Biosciences says ISS, Glass Lewis endorse Gilead deal
The Fly on the Wall
Friday, January 18, 2013 - 10:22am
tags:
YM BioSciences, Gilead, M&A
FDA fast tracks two new lung cancer drugs
PM Live
Friday, January 18, 2013 - 10:17am
tags:
fast track, FDA, Boehringer Ingelheim, Astellas, Roche, Afatinib, Tarceva, non-small cell lung cancer
Forest Labs says Canadian regulators approved its high blood pressure drug Bystolic
Yahoo/AP
Friday, January 18, 2013 - 10:15am
tags:
Forest Labs, Canada, antihypertensives, Bystolic
Why This Pharma is Set for a Great 2013
Motley Fool
Friday, January 18, 2013 - 10:14am
tags:
Sanofi
Cubist Pharmaceuticals Inc Fourth Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Friday, January 18, 2013 - 10:14am
tags:
earnings, Cubist Pharmaceuticals
EU agency backs Pfizer leukemia drug
Reuters
Friday, January 18, 2013 - 10:13am
tags:
Europe, Pfizer, Bosulif, leukemia
Pharma's Reputation Continues to Suffer -- What Can Be Done To Fix It?
Forbes
Friday, January 18, 2013 - 10:10am
tags:
pharma industry
Par Pharmaceutical Sued by Horizon Over Generic Duexis Drug
Bloomberg
Friday, January 18, 2013 - 10:09am
tags:
Par Pharmaceutical, generics, Duexis, Horizon Pharma
NuPathe Wins U.S. FDA Approval for Migraine Skin Patch
Bloomberg
Friday, January 18, 2013 - 9:21am
tags:
NuPathe, FDA, migraines, Zecuity
The Biggest Loser in the Obesity Drug Market
Motley Fool
Friday, January 18, 2013 - 9:20am
tags:
obesity, Vivus, Qsymia, Belviq, Arena Pharmaceuticals, Orexigen, Contrave
Shifts in Roche's Top Brass
Yahoo/Zacks.com
Friday, January 18, 2013 - 9:19am
tags:
Roche
FTC: Pay-to-Delay Pharma Deals Cover $8.3 Billion in Revenue
Yahoo/YCharts
Friday, January 18, 2013 - 9:18am
tags:
FTC, pay-for-delay
AbbVie, Abbott Spinoff, Starts Life Near Top of Pharma Industry’s Dividend-Yield Heap
Yahoo/YCharts
Friday, January 18, 2013 - 9:17am
tags:
AbbVie, dividends
Dendreon Just Raised the Bar
Motley Fool
Friday, January 18, 2013 - 9:16am
tags:
Dendreon, Provenge
IPO could value Pfizer's Zoetis at up to $12.5 bln
Reuters
Friday, January 18, 2013 - 9:15am
tags:
Pfizer, animal health, IPO, Zoetis
EU agency confirms suspension of Merck cholesterol drug
Reuters
Friday, January 18, 2013 - 9:13am
tags:
Europe, Tredaptive, Merck
Abbott Earnings: An Early Look
Motley Fool
Friday, January 18, 2013 - 9:10am
tags:
earnings, Abbott Laboratories
BioCryst Makes A Small Recovery Following Last Year's Bad News
Seeking Alpha
Thursday, January 17, 2013 - 10:43am
tags:
Biocryst, BCX5191
FDA approves egg-free flu vaccine Flubok
Pharma Times, UK
Thursday, January 17, 2013 - 10:31am
tags:
FDA, flu vaccine, Flubok, Protein Sciences
Genentech takes Exelixis drug into Phase III melanoma trial
Bizjournals.com
Thursday, January 17, 2013 - 10:19am
tags:
Exelixis, Genentech, melanoma, Roche, Zelboraf, GDC-0973

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.